I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 8 studies | 19% ± 5% | |
| glutamatergic neuron | 4 studies | 43% ± 16% | |
| GABAergic neuron | 3 studies | 43% ± 7% | |
| astrocyte | 3 studies | 37% ± 13% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 8 studies | 19% ± 5% | |
| glutamatergic neuron | 4 studies | 43% ± 16% | |
| GABAergic neuron | 3 studies | 43% ± 7% | |
| astrocyte | 3 studies | 37% ± 13% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 36% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 744.10 | 1443 / 1445 | 99% | 8.60 | 181 / 183 |
| lung | 100% | 962.58 | 578 / 578 | 96% | 7.23 | 1113 / 1155 |
| breast | 100% | 1178.79 | 459 / 459 | 93% | 12.09 | 1037 / 1118 |
| stomach | 99% | 535.17 | 356 / 359 | 93% | 6.75 | 266 / 286 |
| intestine | 100% | 676.25 | 965 / 966 | 92% | 6.10 | 486 / 527 |
| skin | 100% | 975.51 | 1802 / 1809 | 89% | 8.04 | 421 / 472 |
| pancreas | 97% | 370.34 | 317 / 328 | 92% | 6.12 | 163 / 178 |
| kidney | 100% | 449.64 | 89 / 89 | 87% | 10.29 | 788 / 901 |
| brain | 88% | 350.81 | 2326 / 2642 | 95% | 7.31 | 669 / 705 |
| uterus | 100% | 720.38 | 170 / 170 | 82% | 5.28 | 377 / 459 |
| prostate | 99% | 513.06 | 243 / 245 | 82% | 5.66 | 414 / 502 |
| bladder | 100% | 650.95 | 21 / 21 | 81% | 4.93 | 406 / 504 |
| ovary | 100% | 577.46 | 180 / 180 | 80% | 4.38 | 344 / 430 |
| thymus | 100% | 938.60 | 652 / 653 | 80% | 5.18 | 482 / 605 |
| adrenal gland | 98% | 624.64 | 254 / 258 | 68% | 3.37 | 156 / 230 |
| liver | 92% | 312.15 | 209 / 226 | 57% | 2.65 | 231 / 406 |
| adipose | 100% | 1441.48 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 636.45 | 241 / 241 | 0% | 0 | 0 / 0 |
| muscle | 100% | 669.36 | 801 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 614.95 | 1327 / 1335 | 0% | 0 | 0 / 0 |
| heart | 97% | 629.16 | 831 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 82% | 7.73 | 37 / 45 |
| peripheral blood | 68% | 420.82 | 636 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 64% | 2.60 | 51 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 55% | 3.37 | 16 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0035723 | Biological process | interleukin-15-mediated signaling pathway |
| GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
| GO_0042110 | Biological process | T cell activation |
| GO_0009897 | Cellular component | external side of plasma membrane |
| GO_0005576 | Cellular component | extracellular region |
| GO_0045121 | Cellular component | membrane raft |
| GO_0005515 | Molecular function | protein binding |
| GO_0042289 | Molecular function | MHC class II protein binding |
| GO_1990782 | Molecular function | protein tyrosine kinase binding |
| Gene name | MFAP3 |
| Protein name | Microfibril-associated glycoprotein 3 Microfibril associated protein 3 |
| Synonyms | |
| Description | FUNCTION: Component of the elastin-associated microfibrils. |
| Accessions | A0A7P0TA61 ENST00000519928.2 E5RJ59 ENST00000522782 P55082 A0A7P0TB88 ENST00000679729.1 ENST00000439768.2 [P55082-2] ENST00000522782.6 [P55082-1] ENST00000322602.9 [P55082-1] ENST00000681641.1 ENST00000520899.1 ENST00000522177.1 E5RH26 E5RHQ6 |
